文献速递免疫规划

表达腐败梭菌无毒α毒素结构域的重组乳酸乳球菌口服疫苗可对火鸡梭菌性皮炎提供保护

Recombinant Lactococcus lactis-based oral vaccine expressing non-toxic alpha toxin domains of Clostridium septicum can offer protection against Clostridial dermatitis in turkeys.
PubMed 文献 · Vaccine · 2025-10-04

本研究利用pNZ8124-NICE载体®的乳酸乳球菌(Str. NZ9000)克隆系统表达腐败梭菌α毒素无毒结构域ntATX-D1和ntATX-D2,在火鸡7、8、9周龄时口服免疫,末次免疫后一周以强毒腐败梭菌攻击。结果显示两种载体疫苗均能有效预防死亡,其中携带ntATX-D2的疫苗通过大体和组织病理学评估显示显著更强的保护性免疫,免疫鸟产生抗原特异性血清IgY抗体,且皮肤、肌肉、脾和盲肠扁桃体组织中促炎细胞因子基因表达显著降低。

要点

  • 表达ntATX-D2的乳酸乳球菌口服疫苗可对火鸡梭菌性皮炎提供保护性免疫。
  • ntATX-D2疫苗较ntATX-D1疫苗诱导显著更强的保护性免疫。
  • 免疫火鸡产生抗原特异性血清IgY抗体,促炎细胞因子基因表达显著降低。

核心结论

  • 表达腐败梭菌α毒素ntATX-D2的乳酸乳球菌口服重组疫苗可对火鸡梭菌性皮炎提供保护性免疫,为基于益生菌的口服疫苗防控家禽重要梭菌病提供了新思路。

研究设计与样本

  • 研究利用pNZ8124-NICE载体®的乳酸乳球菌(Str. NZ9000)克隆系统表达ntATX-D1和ntATX-D2蛋白,在火鸡7、8、9周龄时口服免疫,末次免疫后一周以强毒腐败梭菌攻击。

主要发现

  • ntATX-D1和ntATX-D2载体乳酸乳球菌疫苗均能有效预防死亡,但ntATX-D2疫苗通过大体和组织病理学评估显示显著更强的保护性免疫。
  • 免疫鸟产生抗原特异性血清IgY抗体。
  • 与未免疫且经腐败梭菌攻击的对照组相比,乳酸乳球菌-ntATX-D2免疫火鸡的皮肤、肌肉、脾和盲肠扁桃体组织中促炎细胞因子(白细胞介素-1β、IL-6或干扰素-γ)基因表达显著降低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clostridial dermatitis (CD), caused by the anaerobic spore-forming Clostridium septicum bacteria, is an important emerging disease of turkeys. Despite its economic burden on the poultry industry, there are no efficacious vaccines currently available for CD control in turkeys. We recently identified two non-toxic domains of C. septicum alpha toxin (ntATX), namely ntATX-D1 and ntATX-D2, and showed that subcutaneous immunization of turkeys with purified recombinant subunit ntATX proteins can offer protection against CD. In the present study, we used the pNZ8124-NICE vector®-based Lactococcus lactis (Str. NZ9000) cloning system to express ntATX-D1 and ntATX-D2 proteins, and immunized turkeys orally at 7, 8 and 9 weeks of age followed by a virulent C. septicum challenge at one-week post-last immunization. Results showed that while both ntATX-D1 and ntATX-D2 vectored-L. lactis vaccines could effectively prevent mortality, the ntATX-D2 carrying vaccine conferred significantly stronger protective immunity, as determined by the gross and histopathological evaluations. Additionally, the immunized birds were found to have antigen-specific serum IgY antibodies. Furthermore, the L. lactis-ntATX-D2 vaccinated turkeys had significantly reduced expression of pro-inflammatory cytokine (Interleukin-1β, IL-6 or Interferon-γ) genes in the skin, muscle, spleen and cecal tonsil tissues when compared to unvaccinated and C. septicum-challenged control group. Our findings show that a L. lactis-based oral recombinant vaccine expressing ntATX-D2 of C. septicum alpha-toxin can provide protective immunity against CD in turkeys, and thus providing a novel scope for devising probiotic-based oral vaccines against important Clostridial diseases in poultry.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. John FA, Criollo V, Gaghan C, et al. Recombinant Lactococcus lactis-based oral vaccine expressing non-toxic alpha toxin domains of Clostridium septicum can offer protection against Clostridial dermatitis in turkeys. Vaccine. 2025. PMID: 41046832. doi:10.1016/j.vaccine.2025.127801

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。